| 2020-11-12 | Versant Venture Capital VI, L.P. | - | Sell | 47 | $35.15 | $1,651.99 | - | → |
| 2020-11-11 | Roberts Christopher D. | Chief Scientific Officer | Sale+OE | 5,000 | $34.90 | $174,500.00 | -100% | → |
| 2020-11-11 | Versant Venture Capital VI, L.P. | - | Sell | 39,583 | $34.11 | $1,350,353.79 | -0.1% | → |
| 2020-11-11 | Bolzon Bradley J PhD | - | Sell | 39,583 | $34.11 | $1,350,353.79 | -0.1% | → |
| 2020-11-09 | Leggett Thomas | Chief Financial Officer | Sale+OE | 3,000 | $32.96 | $98,891.70 | -100% | → |
| 2020-11-09 | Versant Venture Capital VI, L.P. | - | Sell | 9,400 | $33.08 | $310,948.63 | - | → |
| 2020-11-09 | Bolzon Bradley J PhD | - | Sell | 9,400 | $33.08 | $310,948.63 | - | → |
| 2020-11-05 | Bolzon Bradley J PhD | - | Sell | 11,348 | $33.14 | $376,126.56 | - | → |
| 2020-11-05 | Versant Venture Capital VI, L.P. | - | Sell | 11,348 | $33.14 | $376,126.56 | - | → |
| 2020-11-03 | Roberts Christopher D. | Chief Scientific Officer | Sale+OE | 2,500 | $31.95 | $79,873.00 | -100% | → |
| 2020-11-02 | Epstein David M. | See Remarks | Sale+OE | 12,000 | $31.14 | $373,656.39 | -0.8% | → |
| 2020-10-27 | Versant Venture Capital VI, L.P. | - | Sell | 8,903 | $33.28 | $296,293.17 | - | → |
| 2020-10-27 | Bolzon Bradley J PhD | - | Sell | 8,903 | $33.28 | $296,293.17 | - | → |
| 2020-10-19 | Versant Venture Capital VI, L.P. | - | Sell | 4,233 | $33.43 | $141,513.00 | - | → |
| 2020-10-19 | Bolzon Bradley J PhD | - | Sell | 4,233 | $33.43 | $141,513.00 | - | → |